(Q40928151)

24 September 2017

1 reference

title

Lower respiratory tract infection therapy--the role of ciprofloxacin (English)

1 reference

24 September 2017

A P Ball

1

1 reference

PubMed ID

8529774

24 September 2017

G S Tillotson

series ordinal

2

1 reference

24 September 2017

1 September 1995

1 reference

Journal of International Medical Research

24 September 2017

1 reference

24 September 2017

23

1 reference

24 September 2017

5

1 reference

24 September 2017

315-327

1 reference

Fluoroquinolones in upper respiratory tract infections

24 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Temafloxacin syndrome: review of 95 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Inappropriate use of oral ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Treatment of respiratory tract infections with ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

A randomized study comparing low dose ciprofloxacin and ofloxacin in the treatment of lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Ciprofloxacin in acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitis. A double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Silent myocardial ischemia during mastication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Use of oral ciprofloxacin in community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Ciprofloxacin in the treatment of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059502300501

10.1177/030006059502300501

21 January 2018

Identifiers

DOI

0 references

PubMed ID

8529774

1 reference

PubMed ID

8529774